AG2R La Mondiale Gestion d'Actifs’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.06M Buy
251,615
+20,556
+9% +$538K 0.22% 86
2026
Q1
$6.49M Buy
231,059
+3,059
+1% +$81.4K 0.29% 70
2025
Q4
$5.68M Buy
228,000
+13,392
+6% +$338K 0.25% 79
2025
Q3
$5.2M Hold
214,608
0.27% 74
2025
Q2
$5.2M Buy
214,608
+4,078
+2% +$95.1K 0.27% 74
2025
Q1
$4.95M Buy
+210,530
New +$5.51M 0.27% 73

Other funds holding PFE

AG2R La Mondiale Gestion d'Actifs's PFE Position: Q2 2026 in Review

AG2R La Mondiale Gestion d'Actifs increased its Pfizer (PFE) stake by 8.9% in Q2 2026, buying an estimated $538K and bringing the position to 251,615 shares worth $6.06M. The position accounts for 0.22% of the portfolio, ranked #86.

AG2R La Mondiale Gestion d'Actifs first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.49M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • AG2R La Mondiale Gestion d'Actifs held 251,615 shares of Pfizer worth $6.06M as of Q2 2026.
  • AG2R La Mondiale Gestion d'Actifs bought 20,556 Pfizer shares in Q2 2026, an estimated $538K.
  • Pfizer made up 0.22% of AG2R La Mondiale Gestion d'Actifs's portfolio in Q2 2026, its #86 holding.
  • AG2R La Mondiale Gestion d'Actifs first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
  • AG2R La Mondiale Gestion d'Actifs's Pfizer position peaked at $6.49M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on AG2R La Mondiale Gestion d'Actifs's 13F filing for Q2 2026, filed 23 Jul 2026.